In the present study, we developed a nine-gene signature consisting of GTSE1, LRRN4CL, CRYAB, SHOX2, ASNS, KRT23, ANGPT2, HOXA9, and CARD11 for predicting HNSCC prognosis. Here, SHOX2 is linked to head and neck squamous cell carcinoma.